Emerging Views On Emerging Markets: Q2 Commentary On GSK China Controversy
This article was originally published in PharmAsia News
Executive Summary
PharmAsia News takes a closer look at what pharma executives have had to say so far about the evolving GSK China bribery scandal during second quarter calls with analysts.